China should emphasize key issues inherent in rational medication management for the elderly

Qi Tang; Cao Wang; Wenhui Wu; Yu Cao; Gang Chen; Jun Lu

doi:10.5582/bst.2021.01254

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

China should emphasize key issues inherent in rational medication management for the elderly

Qi Tang, Cao Wang, Wenhui Wu, Yu Cao, Gang Chen, Jun Lu

著者情報

Qi Tang
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.
Cao Wang
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.
Wenhui Wu
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.
Division of Drug Administration, Shanghai Municipal Health Commission, Shanghai, China.
Yu Cao
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.
Gang Chen
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.
Jun Lu
School of Public Health, Fudan University, Shanghai, China.
China Research Center on Disability, Fudan University, Shanghai, China.
Key Laboratory of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.

キーワード: polypharmacy, aging of the population, clinical pharmacy, medication compliance

ジャーナルフリー早期公開

論文ID: 2021.01254

DOI https://doi.org/10.5582/bst.2021.01254

この記事には本公開記事があります。

The final version of this article is now available: Vol. 15 (2021), No. 4 pp. 262-265

詳細

抄録

According to China's Seventh National Census, 18.70% of a total of 1.41 billion people were 60 or older and 13.50% were 65 or older, so China's population is increasingly aging. In conjunction with China's socioeconomic and scientific and technological development and its promotion of medical insurance-related policies, rational medication management for the elderly is a concern in order to control the risk of polypharmacy. This paper summarizes and discusses the following five key issues inherent in rational medication management: i) an increase in serious polypharmacy and the potential risks of medication; ii) a lack of medication consultation service and medication withdraw without healthcare providers' supervision; iii) poor medication compliance among the elderly; iv) insufficient quantity and incompetence of pharmaceutical staffing; and v) limited awareness of pharmaceutical services and lack of trust in the ability of pharmacists. Based on a discussion of factors influencing these issues, suggestions have been put forward in the hopes that China emphasizes rational medication management in order to reduce the risk of polypharmacy and the disease burden of the elderly in China.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）